Profound Medical

Profound Medical

Health Care Equipment & Supplies
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

$264.1M

Market Cap • 11/6/2026

2014

(12 years)

Founded

2016

(10 years ago)

IPO

NASDAQ

Listing Exchange

Flag of Canada

Canada

Country

Valuation

P/B

6,2

P/S

11,2

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

1,2

EPS

—

Market Cap

Market Cap

264,1M

EV

238,1M

EV/Revenue

10,1

EV/EBITDA

-7

EV/EBIT

-6,9

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-312,1M

Profitability

Gross Margin

73,9%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

88,9%

Capex/Revenue

0%

Capex/D&A

0%

Capex/OCF

0%

SBC/OCF

—

% PPE

5,4%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

22%

CAGR Op. Income 5Y

13,9%

CAGR Net Income 5Y

3%

CAGR EPS 5Y

-8%

CAGR OCF 5Y

4,9%

Leverage

N.D./EBITDA

0,8

Debt/Equity

0%

Current Ratio

4,5

Quick Ratio

3,7

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium